3 results
Approved WMOCompleted
The primary objectives of this study are:- To explore the therapeutic effect of eluxadoline in treating IBS-D in pediatric patients 6-17 years of age.- To evaluate the pharmacokinetics (PK) of eluxadoline in pediatric patients with IBS-D.- To…
Approved WMOPending
The main objective of this Phase IIa/b study is to demonstrate the effectof zibotentan on HVPG, and that dapagliflozin can mitigate fluid retention safety concernsregarding its use in this population.
Approved WMOCompleted
· To evaluate the effect of zibotentan anddapagliflozin in combination and alone versusplacebo on UACR.